Sihuan Pharmaceutical Holdings Group Ltd ($460) - buy or sell? Stock discussion, ideas, forum

Sihuan Pharmaceutical Holdings Group Ltd

Sihuan Pharmaceutical Holdings Group Ltd.

Industry: Pharmaceuticals

Ticker	Exchange	ISIN	Name
$460	HKEx Main Board	BMG8162K1137	Code: 460

Recent news

TAI Ping Carpet International Ltd revenue jumped on 34.8% while EBITDA Margin decreased on 2.8 pp from 9.9% to 7.1%

Vision Fame International Holding Ltd revenue growth accelerated from 2.3% in FY2019 to 405% in FY2020

Kantone Holdings Ltd reports 13.0% EBITDA growth in 2020 and 0.61 pp EBITDA Margin growth from 5.7% to 6.3%

Heng Tai Consumables Group Ltd revenue dropped on 35.5% and EBITDA Margin dropped on 19.0 pp from -27.6% to -46.6%

Yat Sing Holdings Ltd revenue decreased on 8.4% and EBITDA Margin decreased on 2.2 pp from -1.7% to -3.9%

Art Textile Technology International Co Ltd Net Debt / EBITDA surged on 82.8x from 3.9x to 86.8x in 2020 while Revenue dropped on 24.7%

China Zenith Chemical Group Ltd revenue dropped on 39.8% while EBITDA Margin surged on 93.4 pp from -149% to -55.4%

Odella Leather Holdings Ltd revenue returned to growth in FY2020: increased 60.4% vs. 48.6% decline a year earliner

New World Development Co Ltd Net Income dropped on 85.3% and Revenue dropped on 23.1%

NWS Holdings Ltd reports 80.3% Net Income decline in 2020 and 3.4% Revenue decline

Twit about 460 stock

Share your investment idea or question on Sihuan Pharmaceutical Holdings Group Ltd stock:

Latest twits on Sihuan Pharmaceutical Holdings Group Ltd (460)

No twits yet. Be the first to post!

Have a question about 460? Ask and other investors will be eager to help you.

Have an idea about 460? Share it with other investors.

Sihuan Pharmaceutical Holdings Group Ltd news

29/03/2016 Sihuan Pharmaceutical Holdings Group Ltd EBITDA surged on 35.1% in 2015 and EBITDA Margin jumped on 22.4 pp from 70.9% to 93.3%

Sihuan Pharmaceutical Holdings Group Ltd stock price chart

Sihuan Pharmaceutical Holdings Group Ltd financials

mln. CNY	FY2010	FY2011	FY2012

Revenue	1,037	2,242	3,043
EBITDA	649.4	1,085	1,179
Net income	522.1	824.0	904.4
CAPEX	107.8	261.4	634.7
Debt	0.000	5.880	773.1
Cash	5,851	3,153	1,544

Sihuan Pharmaceutical Holdings Group Ltd news

29/03/2016 Sihuan Pharmaceutical Holdings Group Ltd EBITDA surged on 35.1% in 2015 and EBITDA Margin jumped on 22.4 pp from 70.9% to 93.3%

About Sihuan Pharmaceutical Holdings Group Ltd

Sihuan Pharmaceutical Holdings Group Ltd. researches and develops cardiocerebral vascular drugs in China. The Company drugs address needs in the areas of anti-infective, metabolism, cardiovascular system, oncology and nervous system.